Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-10-05

Clinical Trial Update: Vasopressin or Norepinephrine in Vasoplegic Shock After Non-cardiac Surgery [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing vasopressin versus norepinephrine in vasoplegic shock after non-cardiac surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: University of Sao Paulo | Conditions: Circulatory Shock, Non-cardiac Surgery | Phase 2, Phase 3 | Status: WITHDRAWN